Large gap with delayed quotes
|
Last quote
04/27/2026
-
19:08:55
|
Bid
04/27/2026 -
19:15:16
|
Bid Volume |
Ask
04/27/2026 -
19:15:16
|
Ask Volume |
|---|---|---|---|---|
|
52.96
+0.07
(
+0.13% )
|
52.95
|
2,000 |
52.96
|
4,800 |
Analysis date: 24.04.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 21.04.2026.
Interest
Weak
Weak
Two stars since 21.04.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 24.04.2026 at a price of 52.89.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 21.04.2026.
4wk Rel Perf
-2.67%
-2.67%
The four-week dividend-adjusted underperformance versus SP500 is 2.67%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 21.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -6.29%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.42%.
Mkt Cap in $bn
6.10
6.10
With a market capitalization between $2 & $8bn, TERNS PHARMACEUTICALS is considered a mid-cap stock.
G/PE Ratio
-0.90
-0.90
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-28.46
-28.46
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-25.65%
-25.65%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
6
6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
-56
-56
For 1% of index variation, the stock varies on average by -0.56%.
Correlation
-0.12
-0.12
Stock movements are strongly independent of index variations, with an even divergent trend.
Value at Risk
42.60
42.60
The value at risk is estimated at USD 42.60. The risk is therefore 80.55%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.04.2026
21.04.2026